Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation.

By T. McLellan, D. Lewis, C. O'brien, H. Kleber. Journal of the American Medical Association (JAMA), 2000

2,598 citations recorded by the source corpus.

Subfields: Cellular and Molecular Neuroscience, Epidemiology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/a575706c26cb86771c31fe35eef669aa29ad975f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cellular and Molecular Neuroscience

In Epidemiology

In Pathology and Forensic Medicine

Citations in the corpus

TREE-BASED REINFORCEMENT LEARNING FOR ESTIMATING OPTIMAL DYNAMIC TREATMENT REGIMES (2018, methodology): “and MURPHY, S. A. (2012). Examining moderated effects of additional adolescent substance use treatment: Structural nested mean model estimation using inverse-weighted regression-with-residuals Technical Report No.”
Efficacy and Tolerability of Long-Acting Injectable Naltrexone for Alcohol Dependence: A Randomized Controlled Trial (2005, background): “Similar to diabetes, hypertension, and asthma, alcohol dependence is increasingly recognized as a chronic disease in which genetic vulnerability and social and environmental factors are involved in the etiology and course of the disease.(7) As with other chronic diseases, long-term comprehensive man”
Addiction: a disease of learning and memory. (2005, background): “An important characteristic of addiction is its stubborn persistence (1, 2).”
Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. (2007, methodology): “These interventions have efficacy comparable with many routine treatments for other diseases.(126) The NIAAA clinician’s guide(127) provides brief, clear instructions on screening and intervention for alcohol problems, and training packages for these procedures are available.”
Prefrontal–striatal pathway underlies cognitive regulation of craving (2010, background): “This ability is perhaps no more important than for individuals with substance use disorders (SUDs), which are chronic relapsing conditions (2, 3) with staggering social costs (4).”
Relative Efficacy of Mindfulness-Based Relapse Prevention, Standard Relapse Prevention, and Treatment as Usual for Substance Use Disorders (2014, methodology): “64 31 Included in 12-mo analysis Excluded from analysis Reasons for exclusion from analysis across all follow-up assessments for (1) mindfulness-based relapse prevention (MBRP): withdrew from the study, enrolled as inpatient, incarcerated, refused, and unable to contact; (2) standard relapse prevent”
Developing adaptive treatment strategies in substance abuse research. (2007, neutral): “researchers (Donovan, 1986; Brown, 1998;O'Brien and McLellan, 1996;McLellan et al., 2000;McLellan, 2002).”
The stigma of alcohol dependence compared with other mental disorders: a review of population studies. (2011, background): “in alcoholism with other chronic medical conditions like diabetes or hypertension, where such changes do not occur more frequently (McLellan et al., 2000).”
Neural mechanisms of addiction: the role of reward-related learning and memory. (2006, background): “As a result, no treatment episode can be considered curative, and for the most seriously addicted individuals, relapses often occur long after any withdrawal symptoms have subsided (McLellan et al. 2000).”